- | Country : -
- | organs : -
- | Specialty : -
Extract
To assess whether the combination of solifenacin succinate (3, 6, 9 mg) and tamsulosin OCAS 0.4 mg provides improved efficacy compared to tamsulosin OCAS 0.4 mg alone in males with LUTS associated with BPH.
Inclusion criteria
- Lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia